Send me a link:

*Text messaging rates may apply.

 Dow Down0.02% Nasdaq Down0.04%

Innovus Pharmaceuticals, Inc. (INNV)

-Other OTC
0.20 0.00(0.00%) Jul 24, 2:49PM EDT
ProfileGet Profile for:
Innovus Pharmaceuticals, Inc.
9171 Towne Centre Drive
Suite 440
San Diego, CA 92122
United States - Map
Phone: 858-964-5123
Fax: 858-249-7879
Website: http://www.innovuspharma.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:2

Business Summary 

Innovus Pharmaceuticals, Inc., a pharmaceutical company, is engaged in the commercialization, licensing, and development of non-prescription pharmaceutical and consumer health products in the United States and internationally. Its male and female sexual health and vitality products include EjectDelay, an over-the-counter monograph-compliant benzocaine-based topical gel for treating premature ejaculation; CIRCUMserum, a non-medicated cream to alleviate reduced penile sensitivity; Zestra, a non-medicated patented natural product to increase desire and arousal, and reduce pain from sexual intercourse in women; and Zestra Glide, a clinically tested water-based longer lasting lubricant. The company also provides pain management products comprising Apeaz, an OTC monograph-compliant topical cream for the relief of arthritis pain; and Xyralid, an OTC monograph compliant lidocaine-based spray in development for the relief of hemorrhoids. It markets its products directly or through commercial partners to primary care physicians, urologists, gynecologists, and therapists; and directly to consumers through on-line channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. is based in San Diego, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Innovus Pharmaceuticals, Inc.

Key Executives 
 PayExercised
Dr. Bassam B. Damaj Ph.D., 46
Chief Exec. Officer, Pres and Director
0.000.00
Ms. Lynnette Dillen CPA, 45
Chief Financial Officer, Principal Accounting Officer and Exec. VP
N/AN/A
Mr. Randy J. Berholtz Esq., J.D., 52
Acting Gen. Counsel and Sec.
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders